News
Autonomix Medical
AMIX · NASDAQ
$2.61−$0.04 (−1.51%)TodayMarket closed ·
Prev close $2.65
Latest news
- Press releaseGlobe Newswire
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
- Press releaseGlobe Newswire
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Market-Moving News for August 25th
- NewsAvi Kapoor
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- NewsTanya Rawat
Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsShivdeep Dhaliwal
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsHenry Khederian
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsMohd Haider
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- NewsAvi Kapoor
Silver Rises Sharply; Chicago PMI Surges In December
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Nasdaq Turns Higher; NY Manufacturing Activity Surges In November
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
Autonomix Medical Commences GLP Preclinical Study Required By FDA At CBSET For Sensing And RF Ablation System As Treatment For Pancreatic Cancer Pain
- Press releaseGlobe Newswire
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System
- Press releaseGlobe Newswire
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
- Press releaseGlobe Newswire
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
- Press releaseGlobe Newswire
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.